ABBV
AbbVie Inc.
NYSE · USHealthcareDrug Manufacturers - General
$253.38-0.44%
Price as of Jul 20, 2026
ABBV capital
AbbVie Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 2.65x
- Net debt / equity
- 2.31x
- Debt / assets
- 0.53x
- Debt / EBITDA
- 4.31x
- Net debt / EBITDA
- 3.75x
Liquidity & coverage
- Current ratio
- 0.80x
- Quick ratio
- 0.68x
- Cash ratio
- 0.22x
- Interest coverage
- 5.96x
- EBITDA / interest
- 5.81x
- Working capital
- -$8.6B
Cash & dividend
- FCF / debt
- 0.29x
- Cash flow / debt
- 0.29x
- Dividend per share
- $6.83
- Dividend yield
- 2.7%
- Dividend growth 1y
- +5.8%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.